ArticleBlood advances2022

Evaluation of allogeneic and autologous membrane-bound IL-21-expanded NK cells for chronic lymphocytic leukemia therapy.

Max Yano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.